These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 8389085

  • 1. A concatenated form of Epstein-Barr viral DNA in lymphoblastoid cell lines induced by transfection with BZLF1.
    Cho MS, Tran VM.
    Virology; 1993 Jun; 194(2):838-42. PubMed ID: 8389085
    [Abstract] [Full Text] [Related]

  • 2. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
    Westphal EM, Mauser A, Swenson J, Davis MG, Talarico CL, Kenney SC.
    Cancer Res; 1999 Apr 01; 59(7):1485-91. PubMed ID: 10197618
    [Abstract] [Full Text] [Related]

  • 3. Latent and lytic Epstein-Barr virus replication strategies.
    Tsurumi T, Fujita M, Kudoh A.
    Rev Med Virol; 2005 Apr 01; 15(1):3-15. PubMed ID: 15386591
    [Abstract] [Full Text] [Related]

  • 4. A molecular link between malaria and Epstein-Barr virus reactivation.
    Chêne A, Donati D, Guerreiro-Cacais AO, Levitsky V, Chen Q, Falk KI, Orem J, Kironde F, Wahlgren M, Bejarano MT.
    PLoS Pathog; 2007 Jun 01; 3(6):e80. PubMed ID: 17559303
    [Abstract] [Full Text] [Related]

  • 5. Strain variation in Epstein-Barr virus immediate early genes.
    Packham G, Brimmell M, Cook D, Sinclair AJ, Farrell PJ.
    Virology; 1993 Feb 01; 192(2):541-50. PubMed ID: 8093650
    [Abstract] [Full Text] [Related]

  • 6. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M, Kikuta H, Ishiguro N, Endo R, Kobayashi K.
    J Med Virol; 2003 Jul 01; 70(3):410-9. PubMed ID: 12767005
    [Abstract] [Full Text] [Related]

  • 7. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
    Ladell K, Dorner M, Zauner L, Berger C, Zucol F, Bernasconi M, Niggli FK, Speck RF, Nadal D.
    Cell Microbiol; 2007 Aug 01; 9(8):2055-69. PubMed ID: 17419714
    [Abstract] [Full Text] [Related]

  • 8. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB, Montalvo EA, McClain KL, Ench Y, Heard P, Christy BA, Dewalt-Hagan PJ, Moyer MP.
    J Med Virol; 1999 Jan 01; 57(1):36-46. PubMed ID: 9890420
    [Abstract] [Full Text] [Related]

  • 9. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene.
    Speck SH, Chatila T, Flemington E.
    Trends Microbiol; 1997 Oct 01; 5(10):399-405. PubMed ID: 9351176
    [Abstract] [Full Text] [Related]

  • 10. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
    Adamson AL, Kenney SC.
    Virology; 1998 Nov 10; 251(1):187-97. PubMed ID: 9813214
    [Abstract] [Full Text] [Related]

  • 11. Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.
    Schepers A, Pich D, Hammerschmidt W.
    Virology; 1996 Jun 15; 220(2):367-76. PubMed ID: 8661388
    [Abstract] [Full Text] [Related]

  • 12. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
    Hsu CH, Hergenhahn M, Chuang SE, Yeh PY, Wu TC, Gao M, Cheng AL.
    Anticancer Res; 2002 Jun 15; 22(6C):4065-71. PubMed ID: 12553034
    [Abstract] [Full Text] [Related]

  • 13. Activation of human thymocytes after infection by EBV.
    Paterson RL, Kelleher CA, Streib JE, Amankonah TD, Xu JW, Jones JF, Gelfand EW.
    J Immunol; 1995 Feb 01; 154(3):1440-9. PubMed ID: 7822809
    [Abstract] [Full Text] [Related]

  • 14. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L.
    Adv Cancer Res; 2007 Feb 01; 97():81-109. PubMed ID: 17419942
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W, Iwakiri D, Yamamoto K, Maruo S, Kanda T, Takada K.
    J Virol; 2007 Jan 01; 81(2):1037-42. PubMed ID: 17079287
    [Abstract] [Full Text] [Related]

  • 16. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C, Bernhard D, Schaadt E, Adler B, Ausserlechner MJ, Mitterer M, Huemer HP.
    Haematologica; 2003 Dec 01; 88(12):1324-35. PubMed ID: 14687985
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT, Fernandes BJ, Mock D.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug 01; 92(2):184-93. PubMed ID: 11505266
    [Abstract] [Full Text] [Related]

  • 18. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
    Chia MC, Leung A, Krushel T, Alajez NM, Lo KW, Busson P, Klamut HJ, Bastianutto C, Liu FF.
    Clin Cancer Res; 2008 Feb 15; 14(4):984-94. PubMed ID: 18281530
    [Abstract] [Full Text] [Related]

  • 19. Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues.
    Takasaka N, Tajima M, Okinaga K, Satoh Y, Hoshikawa Y, Katsumoto T, Kurata T, Sairenji T.
    Virology; 1998 Aug 01; 247(2):152-9. PubMed ID: 9705908
    [Abstract] [Full Text] [Related]

  • 20. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J, Pai S, Cotter M, Robertson ES.
    Virology; 1999 Sep 15; 262(1):18-30. PubMed ID: 10489337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.